HINJ and NJLSVA Host Annual Procurement Conference; Presentations Now Available
New Brunswick, NJ, December 3, 2013 — The HealthCare Institute of New Jersey (HINJ) and the New Jersey Life Sciences Vendors Alliance (NJLSVA) hosted the 2013 Procurement Conference on November 13 at Pfizer Inc. in Peapack, NJ. The forum focused on: The latest trends in pharmaceutical industry outsourcing Issues in Washington, DC and Trenton that […]
‘NJTV News’ Reports on NJ Life Sciences, HINJ’s 2012 Economic Impact Survey
Montclair, NJ, December 2, 2013 ― It has been called the crown jewel of the New Jersey economy. Citing HINJ’s latest economic impact survey, Lauren Wanko reported on “NJTV News with Mike Schneider” that the biopharmaceutical and medical technology industries generated over $26 billion in economic impact for the Garden State in 2012. “We call […]
HINJ Member Companies’ Economic Impact Exceeds $26 Billion in 2012, Finds New Study Conducted in Association with Deloitte
New Brunswick, NJ, November 13, 2013 ― Key findings from the HealthCare Institute of New Jersey’s (HINJ) 2012 economic impact survey indicate that the life sciences continues to play a leading role in driving New Jersey’s economy and reinforces the state’s reputation as the “Medicine Chest of the World.” According to the study, which was […]
HINJ Honors Six at Inaugural Life Sciences Celebration
New Brunswick, NJ, September 26, 2013 ― The HealthCare Institute of New Jersey (HINJ) honored five New Jersey leaders and a nationally recognized high school last evening for their contributions in human health, public service, patient advocacy, life sciences, and science, technology, engineering and mathematics (STEM) education. The awards were presented at HINJ’s inaugural Life […]
HINJ Lauds Congressman Lance for FDA SOS Sponsorship
New Brunswick, NJ, July 18, 2013 ― HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean J. Paranicas issued the following statement in response to Congressman Leonard Lance’s (R-NJ-7) introduction of the FDA SOS (Safety Over Sequestration) Act: * * * “New Jersey’s biopharmaceutical and medical technology companies applaud Congressman Lance for […]
HINJ and BioNJ Commentary: Cost-Cutting Measures Could Stifle Biopharmaceutical Innovation in NJ
Cherry Hill, NJ, July 9, 2013 — The Courier-Post has published a commentary authored by Dean J. Paranicas, HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer, and Debbie Hart, BioNJ President and Chief Executive Officer. * * * New Jersey officials recently announced a plan to reward companies that hire unemployed biopharmaceutical […]
HINJ Testifies Before FDA on Need for Additional 510(k) Premarket Notifications
Silver Spring, MD, June 13, 2013 — HealthCare Institute of New Jersey (HINJ) President and Chief Executive Officer Dean J. Paranicas this morning delivered the following testimony at a meeting of the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) relating to “510(k) Device Modifications: Deciding When to Submit a […]
HINJ Statement on the Passing of The Honorable Frank R. Lautenberg
New Brunswick, NJ, June 3, 2013 ― The HealthCare Institute of New Jersey (HINJ) has released the following statement on the passing this morning of U.S. Senator Frank R. Lautenberg. * * * “Senator Lautenberg was one of our nation’s strongest champions of patients, spending his long legislative career protecting their access to the treatments, […]
HINJ to Host ‘Chronic Disease Management’ Policy Forum on May 23
New Brunswick, NJ, May 16, 2013 — The HealthCare Institute of New Jersey (HINJ) will host a health policy forum titled “Chronic Disease Management: Improving Outcomes & Bending the Cost Curve” on Thursday, May 23 at Forsgate Country Club in Monroe Township. HINJ invites you to join leaders of New Jersey’s healthcare community for a […]
Choose New Jersey, HINJ and Others Promote NJ as Global Life Science Hub at World’s Largest Biotechnology Event
Chicago, IL, April 23, 2013 — To showcase New Jersey as one of the world’s premiere locations for life science companies and medical research, Choose New Jersey, Inc. is collaborating with Lt. Governor Kim Guadagno, the Business Action Center (BAC), the HealthCare Institute of New Jersey (HINJ), BioNJ and other partners at the BIO International […]